- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic kidney disease (CKD)
- Meeting Date: May 2025
- Public Summary Document (PSD) May 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) May 2025 PBAC Meeting - (Word)
Empagliflozin – May 2025
Empagliflozin: Tablet 10 mg; Jardiance®
Last updated
9 May 2025